Female Viagra
Female Viagra
- Where it can be purchased and whether a prescription is required: In regulated markets (including the United States and Canada) flibanserin (Addyi) and bremelanotide (Vyleesi) are prescription-only and normally dispensed from pharmacies with a prescription; however, many products marketed as “female Viagra” are actually sildenafil generics — these are sold over the counter or without a prescription in some countries and by some online pharmacies, so it is possible in certain pharmacies/markets to buy “female Viagra” without a receipt (this carries legal and safety risks).
- What the drug is used for and its mechanism of action: Flibanserin and bremelanotide are approved for hypoactive sexual desire disorder (HSDD) in premenopausal women — flibanserin acts centrally as a 5‑HT1A agonist/5‑HT2A antagonist to increase dopamine and norepinephrine and reduce serotonin, while bremelanotide is a melanocortin receptor (MC4R) agonist that acutely modulates sexual response; sildenafil products marketed as “female Viagra” are PDE5 inhibitors that increase genital blood flow but are not proven or approved for HSDD in women.
- Usual dosage: Flibanserin (Addyi) 100 mg once daily at bedtime; bremelanotide (Vyleesi) 1.75 mg subcutaneous injection given ≥45 minutes before anticipated sexual activity (maximum 1 dose per 24 hours and 8 doses per month); sildenafil products sold as “female Viagra” are commonly available as 50–100 mg tablets but have no approved female HSDD dosing.
- Form of administration: Flibanserin — oral film‑coated tablet taken nightly; bremelanotide — single‑use prefilled subcutaneous autoinjector administered as needed; sildenafil variants — oral tablets.
- Onset time (how fast it starts working): Flibanserin is not immediate and requires continuous nightly dosing with clinical effects evaluated after several weeks (often 4–8 weeks); bremelanotide typically works within about 30–60 minutes (label recommends ≥45 minutes before sex); sildenafil onset is usually 30–60 minutes in men, though efficacy for low desire in women is not established.
- Duration of action: Flibanserin provides benefit with ongoing nightly dosing and is assessed over weeks rather than hours; bremelanotide’s acute effects last for a few hours after injection and dosing is limited to ≤8 times per month; sildenafil’s erectile‑dysfunction effects typically last 4–5 hours in men, with no proven duration for female sexual desire effects.
- Alcohol warning: Strong — flibanserin is contraindicated with alcohol because combining them increases risk of severe hypotension and syncope and patients must avoid alcohol while taking it; for bremelanotide and sildenafil, alcohol can worsen side effects such as dizziness, nausea or low blood pressure, so caution or avoidance is advised.
- Most common side effect: Flibanserin — dizziness, somnolence, nausea, fatigue, insomnia and dry mouth; bremelanotide — nausea, flushing, injection‑site reactions and headache; sildenafil (when used) — headache, flushing, indigestion, nasal congestion and visual disturbances.
- Would you like to try “female viagra” without a prescription?
Basic Female Viagra Information
- INN (International Nonproprietary Name): flibanserin; bremelanotide.
- Brand Names Available In Canada (English): not specified.
- ATC Code: Flibanserin — G02CX01; Bremelanotide — G02CX06.
- Forms & Dosages: Flibanserin 100 mg oral tablet, once daily at bedtime; Bremelanotide 1.75 mg pre‑filled single‑use subcutaneous autoinjector, as needed up to 8 doses/month.
- Manufacturers In Canada (English): not specified.
- Registration Status In Canada (English): not specified.
- OTC / Rx Classification: Prescription only (Rx) for flibanserin and bremelanotide per available product data.
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Many shoppers ask where to find female viagra products in major chains.
Availability at Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu and similar national retailers depends on whether a local wholesaler stocks the product and if a prescriber provides a valid prescription.
Niche speciality drugs such as flibanserin or bremelanotide frequently require special ordering from distributors rather than being standard shelf stock.
Online listings from verified Canadian pharmacies sometimes show stock status, but provincial rules and scope of practice affect dispensing and reimbursement.
Pharmacist consultation often helps secure special orders and ensure safe use.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Canadian online pharmacies increasingly list DIN‑verified products and stock notes.
Provincial formularies and programs such as Ontario Drug Benefit, BC PharmaCare and RAMQ influence whether patients pay out of pocket or receive coverage.
Rules vary by province for pharmacist scope of practice, emergency prescribing and virtual care referrals, which affects access to Rx‑only therapies.
Patients should confirm provincial reimbursement and whether local wholesalers will fulfil special‑orders for flibanserin or bremelanotide.
In our online pharmacy, female viagra is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Price Ranges By Package Size (With Provincial Differences)
Price comparisons for these products vary widely by province and format.
Flibanserin is typically sold as a 30‑tablet bottle (100 mg tablets), while bremelanotide is packaged as single‑use autoinjectors.
Retail price data should be pulled live; pharmacies must populate current CAD prices per pack size and estimate out‑of‑pocket costs after provincial tax and shipping.
| Product | Package | ON Price (CAD) | BC Price (CAD) | QC Price (CAD) | Shipping + Tax |
|---|---|---|---|---|---|
| Flibanserin (flibanserin) | 30 tablets (100 mg) | not specified | not specified | not specified | not specified |
| Bremelanotide (bremelanotide) | Single‑use autoinjector (1.75 mg) | not specified | not specified | not specified | not specified |
- Local Pharmacy Stocking Checklist: confirm DIN, check wholesaler availability, request special order if needed, verify prescriber documentation and counselling time slot.
- Price‑Per‑Dose Table: pharmacy to populate live per province for clear patient estimate.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
Canadians often share experiences on Reddit, HealthBoards and AskDocs when researching treatment for low desire.
Threads in r/Canada and r/TwoXChromosomes discuss access issues, side effects and expectations for medications labelled as female viagra.
Review platforms tend to show mixed reports, with some users noting benefit and others reporting minimal change or bothersome adverse effects.
Patient posts commonly highlight difficulties locating prescribers familiar with HSDD and uncertainty about provincial coverage.
Reported Benefits And Challenges From Canadian Patients
Real‑world Canadian comments emphasize modest increases in desire for some patients, and limited benefit for others.
Top reported benefits include occasional improved desire and increased sexual activity.
Top reported challenges include dizziness, somnolence, nausea, and concerns about alcohol interactions with flibanserin.
Sexual health clinics and community health centres frequently provide counselling before pharmacotherapy to set realistic expectations.
- Top‑Reported Benefits: modest increase in desire; convenience of oral daily dosing (flibanserin); on‑demand effect (bremelanotide).
- Top‑Reported Challenges: side effects (dizziness, nausea), access to prescribers, out‑of‑pocket cost if not covered.
Moderation Note: encourage reporting adverse events to Canada Vigilance and to the dispensing pharmacist for documentation.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
The international nonproprietary names are flibanserin and bremelanotide.
Brand names documented in product data include Addyi (flibanserin) and Vyleesi (bremelanotide) in the United States market.
Sildenafil‑based products are sometimes marketed internationally as "female Viagra" but sildenafil is not approved for HSDD by major regulators.
Legal Classification Under Health Canada
Both flibanserin and bremelanotide are prescription‑only where marketed per the available product information.
Pharmacies must verify Health Canada authorisation and DIN listings before offering a product as marketed in Canada.
| Brand | INN | Typical Packaging | Rx/OTC |
|---|---|---|---|
| Addyi | Flibanserin | 100 mg tablets, 30‑tablet bottles (US market) | Rx |
| Vyleesi | Bremelanotide | 1.75 mg pre‑filled autoinjector (single use) | Rx |
| Vibasuva F (example) | Sildenafil | 100 mg tablets (markets outside Canada) | varies |
- INN: International Nonproprietary Name.
- DIN: Drug Identification Number — verify before sale.
- HSDD: Hypoactive Sexual Desire Disorder.
- Rx: Prescription only.
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
Internationally, flibanserin and bremelanotide are indicated for acquired, generalized HSDD in premenopausal women.
Canadian prescribers refer to Health Canada approvals and DIN listings to determine authorised indications and safety monitoring.
If Health Canada approval or a DIN is not present for a product, prescribers may use specialist judgement and international guidelines, but formal approval status should be checked before dispensing.
Off‑Label Patterns In Canadian Healthcare
Clinicians sometimes consider off‑label approaches for peri‑ or postmenopausal sexual dysfunction, prioritizing hormonal or topical therapies where appropriate.
Non‑pharmacologic interventions such as psychosexual therapy and relationship counselling are often recommended prior to or alongside drug therapy.
- Inclusion Criteria For Therapy: premenopausal, acquired and generalized HSDD after ruling out reversible causes.
- Exclusion Considerations: regular alcohol use (flibanserin), severe liver disease, pregnancy and breastfeeding.
Pharmacy Note: require prescriber documentation and counsel on interactions and monitoring when dispensing these therapies.
How It Works In The Body
Layman’s Explanation (Canadian Patient‑Friendly Tone)
Patients often ask whether these drugs act like male Viagra.
Flibanserin does not work like sildenafil; it is taken daily and aims to rebalance brain neurotransmitters to increase desire over weeks.
Bremelanotide is an on‑demand subcutaneous injection that activates melanocortin receptors and tends to increase responsiveness shortly after dosing.
Both drugs target different pathways than PDE5 inhibitors used in men.
Clinical Detail From Health Canada Resources
Flibanserin produces central neurotransmitter changes—raising dopamine and noradrenaline while reducing inhibitory serotonin activity—requiring nightly dosing for sustained effect.
Bremelanotide acts acutely and should be administered at least 45 minutes before anticipated sexual activity, with monthly dose limits.
- Dopamine: associated with reward and sexual desire.
- Serotonin: can inhibit sexual desire when elevated.
- Melanocortin Receptor: bremelanotide target that stimulates sexual responsiveness.
Pharmacy counselling should set realistic timelines: weeks for flibanserin and about 45 minutes for bremelanotide onset.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
Clear dosing instructions help ensure safety and effectiveness.
Flibanserin standard dosing is 100 mg orally once daily at bedtime.
Bremelanotide standard dosing is 1.75 mg subcutaneously at least 45 minutes before sexual activity, with a maximum of one dose per 24 hours and up to eight doses per month.
Adjustments By Patient Type (With Canadian Clinical Notes)
Dose adjustments are necessary for some patients and contraindicated in others.
Flibanserin is contraindicated in severe hepatic impairment and requires caution with CYP3A4 inhibitors.
Bremelanotide requires caution in hepatic or renal impairment and may need avoidance depending on clinical assessment.
| Drug | Standard Dose | Timing | Max Monthly Dose |
|---|---|---|---|
| Flibanserin | 100 mg | Once nightly at bedtime | Continuous as tolerated; reassess at 8 weeks |
| Bremelanotide | 1.75 mg SC | ≥45 minutes before activity | 8 doses/month; max 1 per 24 h |
- If a dose of flibanserin is missed, skip it and resume the next night; do not double dose.
- If a dose of bremelanotide is missed, do not inject; seek advice if confusion about timing occurs.
Contraindications & Side Effects
Common (Health Canada‑Approved List)
Safety counselling focuses on known contraindications and common adverse effects.
Flibanserin common side effects include dizziness, somnolence, nausea, fatigue, insomnia and dry mouth.
Bremelanotide common side effects include nausea, flushing, injection‑site reactions and headache.
Rare But Serious (With Canadian Pharmacovigilance Data)
Serious risks include hypotension and syncope with flibanserin when combined with alcohol or strong CYP3A4 inhibitors.
Pharmacies should advise immediate medical review for syncope, severe dizziness or other alarming symptoms and report events to Canada Vigilance.
| Event | Frequency | Risk Mitigation |
|---|---|---|
| Dizziness / Somnolence | Common (flibanserin) | Take at bedtime; avoid driving if affected |
| Nausea / Flushing | Common (bremelanotide) | Consider anti‑emetic strategies; counsel on expected profile |
| Hypotension / Syncope | Rare but serious (flibanserin with alcohol) | Strict alcohol avoidance; review concurrent meds |
- Interacting Medication Classes: strong CYP3A4 inhibitors, certain psychotropics — review full med list before dispensing.
- Immediate Actions: stop drug and seek urgent care if severe hypotension or fainting occurs.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
True alternatives for HSDD remain limited and often focus on addressing underlying causes.
| Medication / Option | INN | Typical Indication | Pros / Cons | DIN |
|---|---|---|---|---|
| Flibanserin | Flibanserin | HSDD (premenopausal) | Oral daily; alcohol interaction; modest effect | not specified |
| Vyleesi | Bremelanotide | HSDD (premenopausal) | On‑demand injection; nausea common; requires injection | not specified |
| Local Oestrogen Therapy | Estradiol (topical) | Menopausal Genitourinary Symptoms | Targeted vulvovaginal symptoms; not for generalized HSDD | varies |
| Sildenafil Generics | Sildenafil | ED in men; marketed in some regions as "female Viagra" | Not approved for HSDD; limited evidence in women | varies |
Pros And Cons List
- Flibanserin: Pros — oral daily dosing, central mechanism; Cons — alcohol contraindication, modest average benefit.
- Bremelanotide: Pros — on‑demand dosing, acute effect; Cons — injection required, nausea and handling sharps.
- Non‑Drug Options: Pros — addresses root causes (therapy, relationship work); Cons — may require more time and access to specialists.
Pharmacy Note: include DIN references, provincial formulary status and links to patient education on non‑pharmacologic approaches when advising customers.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent trials and real‑world studies continue to investigate effectiveness, safety and patient selection factors for HSDD therapies.
Studies from 2022–2025 report modest mean effect sizes and highlight the importance of addressing psychosocial comorbidities alongside medication.
Canadian research interest focuses on real‑world registries, provincial formulary evaluations and health‑economics assessments informing reimbursement decisions.
Key Takeaways For Clinicians And Shoppers
- Patient selection matters—those without major psychosocial contributors are likelier to see benefit.
- Average treatment effects are modest; set realistic expectations and use shared decision‑making.
- Monitor safety carefully, especially for flibanserin with alcohol or interacting drugs.
Pharmacy Action: link to PubMed and local guidelines and monitor Health Canada notices for updates to approvals or safety communications.
Common Patient Questions In Canada
Can I drink alcohol on flibanserin?
No — concurrent alcohol raises the risk of hypotension and syncope; advise strict avoidance while taking flibanserin.
Will it work immediately?
Flibanserin typically requires weeks of nightly dosing to assess benefit; bremelanotide acts within about 45 minutes and is used on demand.
Is it covered by provincial drug plans?
Coverage varies and many provincial formularies do not list niche HSDD drugs; check Ontario Drug Benefit, BC PharmaCare and RAMQ for eligibility.
How do I get a prescription?
See a family physician, sexual health clinic or specialist; pharmacists can assist with referral information in many provinces.
Can I import it from the US?
Cross‑border importation is regulated; confirm Health Canada and customs rules before attempting to import medications.
| Question | Quick Answer | Action Item |
|---|---|---|
| Alcohol With Flibanserin | No | Advise strict avoidance; document counselling |
| Onset Of Effect | Flibanserin: weeks; Bremelanotide: ~45+ minutes | Set follow‑up at 4–8 weeks |
| Provincial Coverage | Varies | Check provincial formularies and patient eligibility tools |
Regulatory Status
Health Canada Approval Process
A drug marketed in Canada must have Health Canada authorisation and an assigned DIN.
Manufacturers submit clinical dossiers for review; post‑market surveillance and pharmacovigilance obligations continue after approval.
If a product lacks a Canadian DIN, pharmacies must not present it as Health Canada‑approved; special access or importation pathways may apply under specific conditions.
DIN Number Relevance
The DIN uniquely identifies a marketed drug product in Canada and must be displayed on product pages and labels when the product is marketed in Canada.
- Regulatory Checklist: confirm DIN present, verify label and product monograph, secure necessary import permits if applicable.
- Required Documentation For Shelfing: DIN, product monograph, supplier invoices and appropriate liability coverage.
Pharmacy Operational Note: routinely verify DIN against Health Canada’s online database and flag changes to formulary status.
Visual Recommendations
Infographic Ideas For Canadian Context
Create an "At‑a‑Glance" infographic showing INN, indication (HSDD), dosing summary, onset/timeline, top side effects and the alcohol warning.
Use a small Canada map with provincial icons to indicate coverage variability and a clear Rx‑only badge.
In‑Store Shelf And Web Product‑Card Suggestions
Product cards should feature a high‑visibility DIN field, manufacturer, Rx‑only badge, price per unit and an "Ask A Pharmacist" call to action.
Include patient leaflets in English and French where applicable and an injection technique animation for bremelanotide.
- Comparison Table: Flibanserin vs Bremelanotide with quick facts.
- Timeline Graphic: onset and typical reassessment points.
- Accessibility Note: alt text and readable fonts; bilingual considerations for Quebec.
Buying & Storage Advice
In‑Store Vs. Online Canadian Purchase Tips
Verify the pharmacy is provincially licensed and displays a valid DIN lookup when ordering online.
In‑store purchases at national chains offer face‑to‑face counselling and immediate pharmacist review.
DIN‑verified Canadian online pharmacies can be cost‑effective but confirm shipping policies, storage conditions and return options.
Cross‑border purchases present legal and authenticity risks; advise patients to check Health Canada and customs rules before importing medications.
Proper Storage With Canadian Climate Considerations
Flibanserin: store at room temperature (20–25°C) and protect from moisture.
Vyleesi: protect from light and heat; store at room temperature (15–30°C) per manufacturer guidance.
- Storage Checklist: avoid freezing during winter shipments and avoid prolonged heat exposure during summer transit.
- Sharps Disposal: provide provincial disposal guidance for autoinjector waste.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Start with shared decision‑making and document baseline sexual function, mental health, medication list and alcohol use.
Discuss expected timeframe for flibanserin (reassess at approximately eight weeks) and demonstrate injection technique for bremelanotide.
Monitoring And Follow‑Up
Recommended monitoring includes a baseline assessment, a 4–8 week review for early problems and ongoing pharmacovigilance reporting.
Red flags to stop the drug include severe dizziness, fainting or symptoms suggestive of liver injury.
- Pharmacy Counselling Template: document informed consent, record DIN and batch/lot number, provide patient leaflet and schedule a follow‑up contact.
- Monitoring Calendar: baseline, week 4, week 8, then periodic review or as clinically indicated.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| London | Ontario | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
| Hamilton | Ontario | 5-7 days |
